Office: 637 Salk Hall

Phone: 412-648-3012

Email: inh3@pitt.edu

orcidLinkedIn

Dr. Hernandez earned her PharmD from the University of Navarra (Spain) in 2013, and she completed her clinical training in the North Middlesex University Hospital and Green Light Pharmacy, both in London (UK). Upon graduation, she was selected as 1 in 48 among thousands of graduates in Spain across all disciplines to receive a “La Caixa” fellowship. This prestigious fellowship supported her PhD studies in Health Services Research and Policy at the University of Pittsburgh Graduate School of Public Health. Completed in 3 years, the research conducted during her PhD yielded 11 first-author peer-reviewed publications and 2 press releases. Published in JAMA Internal Medicine and Stroke, some of these studies were among the first to provide evidence on the real-world outcomes of non-vitamin K antagonist oral anticoagulants after their approval, and were featured in media outlets around the world.

Following her graduation, Hernandez was appointed Assistant Professor at the University of Pittsburgh School of Pharmacy in August 2016. Hernandez’s research program at Pitt Phatmacy is built at the intersection of pharmaceutical health services and outcomes research, pharmacoepidemiology, pharmacoeconomics and pharmaceutical policy. Specifically, her current research has 3 main areas of focus:
• Real-world use and outcomes of oral anticoagulation therapy in stroke prevention in atrial fibrillation.
• Use of large data sets, advanced data mining techniques and comparative effectiveness research to predict and compare outcomes of antidementia medications.
• Value-based health insurance and health services delivery:
o Comparing pharmaceutical use, spending and outcomes by health services provider and payer.
o Development of value- and outcomes- based pharmaceutical pricing mechanisms.